Aim: Periodontitis is considered as infection in periodontal supporting structure leading to tooth mobility and ulcerated periodontal pockets. The present study was conducted to assess Sirtuin 3 (SIRT 3) and SIRT 4 level in patients with diabetes mellitus (DM) and periodontitis.
INTRODUCTION
Periodontitis is considered by infection in periodontal supporting structure leading to tooth mobility resulting in bacteremia. This is due to the presence of epithelial cells that show ulcerated periodontal pockets. It causes both local and systemic inflammatory host-immune response. Numerous studies have been conducted which correlate periodontitis and systemic diseases. 1 It is stated that periodontal diseases are the leading cause of initiation and progression of systemic diseases. It has been a matter of interest to establish the relation between periodontitis and systemic health. As a local oral inflammatory disease, periodontitis may induce and promote systemic inflammation that initiates cardiovascular disease, pulmonary disease, rheumatoid arthritis, and DM. 
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Among systemic diseases, DM is a common one which has a link with periodontitis. It is a metabolic disorder characterized by hyperglycemia due to defective secretion or activity of insulin. It is divided into insulindependent DM/type I DM and noninsulin-dependent DM/type II DM. Diabetes mellitus is analyzed by measuring glycated hemoglobin levels in blood, whereas sequential fasting plasma glucose levels is 7 mmol/L or more. 3 The regulation of osteogenic differentiation in human periodontal ligament cells plays an imperative role for the development of new strategies for treating periodontitis. The exact mechanism by which diabetes affects periodontal tissues is not fully explained. It has been observed that there is altered immune-inflammatory response to bacterial pathogens leading to the disease. The SIRT 3 is a mitochondrial localized sirtuin which helps in glucose metabolism by increasing insulin sensitivity. Nasrin et al 4 observed that SIRT 3 stimulates the ketogenesis by activating acetyl-coenzyme A synthetase in the mammalian cells. Thus, we can hope that SIRT 3 might play an important role for the enhanced ketogenesis seen during diabetes.
The SIRT 4 that takes part in glucose metabolism has an additional adenosine diphosphate (ADP)-ribosyl transferase activity which is concerned with telomere maintenance, genomic stability, and longevity. It ADPribosylates and inhibits the mitochondrial glutamate dehydrogenase (GDH). The GDH controls amino acidstimulated insulin secretion by regulating glutamine and glutamate oxidative metabolism. It is found that SIRT 1 and SIRT 4 appear to work in opposite directions to control insulin secretion as both the localization and the function of SIRT 4 are different. 5 Although there is lack of sufficient information regarding the role of sirtuins in the osteogenic potential of human periodontal ligament cells, it is hypothesized that sirtuins regulate differentiation of human periodontal ligament cells and may play a role in periodontal bone regeneration.
So, the present study was conducted to assess the SIRT 3 and SIRT 4 level in patients with DM and periodontitis and its therapeutic efficiency in periodontitis.
MATERIALS AND METHODS
The present study was conducted on 60 subjects. All were informed regarding the study and written consent was obtained. Ethical clearance was taken prior to the study from the institutional ethical committee. Subjects with history of smoking and those on calcium channel blockers were excluded.
General information, such as name, age and gender was recorded. Subjects were divided into four groups, I, II, III, and IV, comprising 15 subjects each. In all subjects, fasting blood glucose level was assessed. Blood samples were obtained from all subjects and processed for assessment of glycated hemoglobin (HbA1C) level. If it was <7, they were considered to be controlled diabetics and those with HbA1C level > 7 were poorly controlled diabetics. Subjects were subjected to PI, BOP index, GI, and CAL.
Plaque index was measured at mesial, lingual, distal, and buccal site and scores given were 0, 1, 2, and 3. The BOP was measured at buccal and mesiobuccal sites. If the percentage of sites with BOP was less than 30 of all probed sites, it was defined as local bleeding. If the percentage of sites with BOP was higher than 30 of all probed sites, then it was considered as general BOP. Gingival index (Loe and Silness) was evaluated by periodontal probe. The GI score was marked as mild (0.1 to 1.0), moderate (1.1 to 2.0), or severe (2.1 to 3.0). Clinical attachment level was calculated by adding gingival recession (GR) and probing depth.
In all subjects, 2 mL of blood was taken in a vial. For the estimation of SIRT 3 and SIRT 4, Western blot analysis was performed. Results thus obtained were subjected to statistical analysis using chi-square test and post hoc analysis using Tukey's test. A p-value less than 0.05 was considered significant.
RESULTS
The mean ± standard deviation (SD) age of group I was 44.13 ± 1.35 years, that of group II 43.53 ± 1.45 years, for group III, it was 43.93 ± 1.22 years, and for group IV, it was 44.47 ± 0.74 years. The difference was statistically nonsignificant (p 0.219) (Graph 1). Out of 15 subjects in each group, males were 10 and females were 5. Graph 2 shows that mean BOP score in group I was 1.92 ± 0.44, in group II, it was 2.25 ± 0.22, in group III, it was 5.31 ± 0.54, and 5.74 ± 0.30 in group IV. The difference was statistically significant (p 0.001) (Graph 2). Mean PI score in group I was 2.25 ± 0.23, in group II, it was 2.26 ± 0.13, in group III, it was 4.37 ± 0.60, and in group IV, it was 3.25 ± 0.16. The difference was statistically significant (p < 0.001). The post hoc analysis using Tukey's test revealed that the difference between groups I and II and between groups III and IV was statistically nonsignificant (p > 0.05). However, the difference of mean PI scores between groups I and II differed significantly from that of groups III and IV. The mean GI score in group I was 0.78 ± 0.23, in group II, it was 0.95 ± 0.18, in group III, it was 8.69 ± 1.13, and 8.89 ± 0.89 in group IV. The difference was statistically significant (p < 0.001). The post hoc analysis using Tukey's test revealed that the difference between groups I and II and between groups III and IV was statistically nonsignificant (p > 0.05). Also the difference was statistically insignificant. However, the difference of mean GI scores between groups I and II differed significantly from that of groups III and IV ( Table 1) .
The descriptive statistics for CAL for two study groups: The mean CAL in group III was 5.66 ± 0.64, while in group IV, it was 6.37 ± 0.30. The difference was statistically significant (p 0.001) ( Table 2) .
The descriptive statistics for fasting blood sugar across four study groups: The mean fasting blood sugar (mg/dL) in group I was 80.40 ± 13.05, in group II, it was 160.40 ± 27.20, in group III, it was 77.00 ± 12.78, and in group IV, it was 264.20 ± 53.17. The difference was statistically significant (p 0.001) ( Table 3) .
The mean expression of SIRT 3 in group I was 29.20 ± 3.14, while in group II, it was 29.19 ± 2.18, group III, it was 28.89 ± 2.77, and group IV, it was 29.59 ± 5.82. The difference was statistically nonsignificant (p 0.972). The mean expression of SIRT 4 in group I was 28.93 ± 12.55, in group II, it was 28.82 ± 9.14, in group III, it was 28.88 ± 6.03, and in group IV, it was 29.05 ± 10.68 (Table 4) .
DISCUSSION
Periodontitis is a disease of periodontium in which there is considerable tooth mobility, pocket formation, and GR. This is due to plaque accumulation in subgingival and supragingival tooth area. Plaque contains considerable bacteria leading to localized infection. The pathogenesis of periodontal disease has been demonstrated in different Chances to periodontitis are increased when there is an enhanced level of interleukins, such as IL1 and IL1 gene polymorphism. Epigenetics and environmental factors changed the expression of deoxyribonucleic acid transcription and through these factors, an individual's predisposition for inflammatory response is determined. In a longitudinal study in patients with type II diabetes, the effect of periodontitis on deaths from cardiovascular complications and diabetic nephropathy has been investigated. Age-and sex-adjusted death rates were 28.4 times higher in subjects with severe periodontitis, 3.7 times higher in subjects with moderate periodontitis, and only 19.6 times in subjects with no/mild periodontitis. 7 In the present study, we included 60 subjects which were divided into four groups of 15 each. Each group comprised of 10 males and 5 females. We found that mean ± SD age of group I was 44.13 ± 1.35 years, for group II, it was 43.53 ± 1.45 years, group III, it was 43.93 ± 1.22 years, and group IV, it was 44.47 ± 0.74 years.
Saito et al. 8 conducted a study and divided subjects into three groups. Group I comprised of subjects with normal glucose tolerance, group II had subjects with impaired glucose tolerance, and group III had subjects with no glucose tolerance (diabetics). The author observed an increase in mean pocket depth in group III (diabetics). It has been observed that hyperglycemia causes increase in oxidative stress which leads to imbalance between reactive oxygen species and antioxidants. This imbalance promotes accumulation of advanced glycation end products (AGE). The binding of AGE to their receptors promotes intracellular events that intensify the production of proinflammatory cytokines, chemokines, and cell adhesion molecules. 9 It has been observed that diabetes further promotes periodontitis through an exaggerated inflammatory response to the periodontal microflora. The increased destruction of periodontal tissue seen in diabetic patients is due to enhanced inflammation in the disease causing destruction and decreased repair of damaged tissues. Periodontal disease has been associated with higher levels of inflammatory mediators, such as tumor necrosis factor-α, IL-1β in people with diabetes. 10 In the present study, we assessed the mean fasting blood sugar (mg/dL) in group I, which was 80.40 ± 13.05, in group II, it was 160.40 ± 27.20, in group III, it was 77.00 ± 12.78, and in group IV, it was 264.20 ± 53.17. The difference was found to be significant. This is in agreement with Ebersole and Cappelli. 11 In the current study, BOP in all groups was assessed. It has been found that mean BOP score in group I was 1.92 ± 0.44, in group II, it was 2.25 ± 0.22, in group III, it was 5.31 ± 0.54, and 5.74 ± 0.30 in group IV. This is in agreement with Sima and Glogauer. 12 Plaque index was evaluated in all the subjects which showed the mean PI score of 2.25 ± 0.23, 2.26 ± 0.13, 4.37 ± 0.60, and 3.25 ± 0.16 in groups I, II, III, and IV respectively. We found that mean GI in group I was 0.78 ± 0.23, in group II, it was 0.95 ± 0.18, in group III, it was 8.69 ± 1.13, and 8.89 ± 0.89 in group IV. This is in agreement with Lamster et al. 13 study which showed that the mean CAL in group III was 5.66 ± 0.64, while in group IV, it was 6.37 ± 0.30. Histone deacetylases, such as SIRT 3 and SIRT 4 are enzymes that play an important role in DM. These are nicotinamide-adenine dinucleotide-dependent deacetylases. The SIRT 3 helps in increasing insulin sensitivity and decreasing blood glucose level. The SIRT 4 has ADP ribosylase activity, which inactivates GDH and in turn inhibits insulin secretion in pancreatic b-cells. 14 We found that the mean expression of SIRT 3 in group I was 29.20 ± 3.14, in group II, it was 29.19 ± 2.18, in group III, it was 28.89 ± 2.77, and in group IV, it was 29.59 ± 5.82. Similarly, the mean expression of SIRT 4 in group I was 28.93 ± 12.55, in group II, it was 28.82 ± 9.14, in group III, it was 28.88 ± 6.03, and in group IV, it was 29.05 ± 10.68. This is in agreement with Haigis and Sinclair. 15 The low level of sirtuins may lead to DM. Recent studies have shown that therapy targeted at activating SIRT 3 has a beneficial effect in patients with DM. 16 Sirtuin 1 has been shown to suppress bone breakdown through the direct activation of FOXO proteins through their deacetylation.
The sirtuin has been shown to activate superoxide dismutase 2, resulting in the diminution of oxidative stress and the inhibition of inflammation-mediated bone loss. So, it can be presumed that it might play an important role as therapeutics for inflammation-induced periodontal bone loss. 17 Lee et al. 18 conducted a study to elucidate the expression of SIRT 1 and osteoblastic differentiation markers and suggested that SIRT 1 is a potent regulator of differentiation of human periodontal ligament cells and have an imperative clinical impact on regeneration of periodontal bone.
CONCLUSION
The association of DM and periodontitis is well known. The SIRT 3 and SIRT 4 are useful indicators of glycemic level in patients with DM, and sirtuins may play a therapeutic role in periodontitis.
